Furans

Furans: A Comprehensive Reference on Natural Furan Derivatives as Dietary and Bioactive Compounds

1. Identity and Classification

1.1 Chemical Definition

Furans belong to a class of organic compounds known as heterocyclic aromatic hydrocarbons. The parent compound, furan, is a five-membered unsaturated cyclic ether (C₄H₄O). It is a very volatile colorless liquid with a boiling point of 31.4 °C. It is only poorly soluble in water but dissolves in organic solvents. As a chemical class, furans encompass an enormous range of naturally occurring and synthetic derivatives in which the furan ring serves as a core structural scaffold. The furan ring — both in its native as well as in its reduced form — occurs in a number of natural products, and these compounds can exhibit remarkable pharmaceutical activity.

1.2 Major Natural Subclasses

The term "furans" as used in nutritional and biomedical contexts typically refers to a spectrum of structurally related, naturally occurring compounds rather than the parent molecule alone. The principal bioactive subclasses include:

• Furan fatty acids (FuFAs): FuFAs, with a distinctive furan ring incorporated into fatty acyl chains, are minor yet bioactive constituents of dietary lipids known for their unique chemical properties. The basic chemical structure of furan fatty acids comprises a furan ring with a carboxyalkyl chain in position 2, an alkyl chain in position 5, and one methyl group in position 3 or two methyl groups in position 3 and 4. The molecule carries a carboxyalkyl chain (typical length 9, 11, or 13 carbon atoms) in the α1-position and a propyl or pentyl chain in the α2-position.
• Furanocoumarins: Furanocoumarins are tricyclic aromatic compounds composed of a furan ring fused to a α-benzopyrone (coumarin) system. The FC structure is characterized by a furan ring attached to carbons 6 and 7 (linear type) or 7 and 8 (angular type) of a benzo-α-pyrone (coumarin).
• Furanones: Furanone is a heterocyclic organic compound classified as an unsaturated lactone. Natural halogenated furanones are isolated from sea organisms, and other natural furanone derivative compounds are found in a number of fruits.
• Agarofurans: Agarofurans are other furan derivatives that can be isolated from plants, trees, fruits, and seeds. Many biological activities of these compounds have been investigated, revealing new insight into their effect on human health regarding cytotoxic, immunosuppressive, antitumor activities, and possible anti-HIV properties.
• Simple furans and methylfurans: The parent furan and its methylated analogues (2-methylfuran, 3-methylfuran) occur in heat-treated foods. The toxicity of methylated derivatives of furan, 2-methylfuran and 3-methylfuran, is conservatively considered to be the same as furan.

2. Natural Sources and Occurrence

2.1 Occurrence in Foods and Precursors

It is reported that furan can be produced from organic acid, vitamin C, reducing sugars, amino acids, polyunsaturated fatty acids, and carotenes in the presence of heat. Furan occurs naturally in oils distilled from rosin containing pinewood. In addition, many natural foods contain the furan ring structure and substituted furans may be formed through cooking of simple carbohydrates.

Toxic heterocyclic compounds such as furan, 5-hydroxymethylfurfural, and 4(5)-methylimidazole are formed in Maillard reaction systems and are accordingly found in large numbers in heat-treated foods and beverages. Furan is also detected in cooked foods, where it is produced through the Maillard reaction — the chemical reaction between amino acids and reducing sugars that gives browned food its distinctive flavour.

Coffee is the most extensively studied dietary source of parent furan. The highest concentrations of furan were found in whole roasted coffee beans, with a mean value of 4,579 μg/kg. High mean concentrations were also found in ground roasted coffee (2,361 μg/kg), unspecified coffee solids (2,186 μg/kg), coffee imitates for brewing (1,922 μg/kg), instant coffee powder (310 μg/kg), and instant coffee imitates (127 μg/kg). From roasting to the cup, furan concentrations decrease because of the high volatility and low water solubility of furan. Through grinding, packaging, storage, and brewing procedures, furan concentrations decrease further.

The highest exposures to furan were estimated for infants, mainly from ready-to-eat meals. Grains and grain-based products contribute most for toddlers, other children, and adolescents. In adults, elderly, and very elderly, coffee is the main contributor to dietary exposure.

2.2 Sources of Furan Fatty Acids (FuFAs)

Furan fatty acids are minor components naturally synthesized mainly by algae, but also by plants and microorganisms. After ingestion, furan fatty acids are predominantly incorporated into phospholipids and cholesterol esters in fish, marine organisms, and mammals. Furan fatty acids originate from dietary sources such as fish, grains, and fish oils. Furan fatty acids are not produced de novo in many animals, including humans.

2.3 Sources of Furanocoumarins

From a chemotaxonomical standpoint, furanocoumarins have been isolated from few genera within a limited group of plant families, including Apiaceae, Fabaceae, Moraceae, and Rutaceae and, to a minor degree, Amaranthaceae, Asteraceae, Cyperaceae, Meliaceae, Pittosporaceae, Rosaceae, and Solanaceae. Apiaceae and Rutaceae provide the larger number of species and the most valuable sources of furanocoumarins for pharmacological and toxicological purposes. In terms of food and medicinal plants, Apiaceae usually harbor, on a fresh-weight basis, a higher content than Rutaceae.

Furanocoumarins are widely distributed in the plant kingdom, particularly within the Rutaceae (citrus family) and Apiaceae (carrot family) families. Specific examples include grapefruit, limes, parsley, parsnip, celery, and angelica. Grapefruit juice contains three major furanocoumarins, including bergamottin, 6′,7′-dihydroxybergamottin, and 6′,7′-epoxybergamottin, as well as numerous minor-occurring furanocoumarins. The concentration of furanocoumarins can vary depending on the plant species, growing conditions, and even the part of the plant consumed. For instance, the peel of citrus fruits often contains higher concentrations than the pulp.

2.4 Sources of Furanones

2,5-Dimethyl-4-hydroxy-3-[2H] furanone (DMHF) or furanone was the first furanone isolated and identified in pineapple. The biological activity of these compounds has been identified in medicinal chemistry. A derivative, 4-hydroxy-3(2H)-furanones, has been isolated from natural sources such as pineapple and strawberry and studied for its potential to inhibit spontaneous cataract formation.

3. Traditional and Historical Use

The traditional use of furans as a class was not recognized as such; rather, plants containing high concentrations of furanic compounds — particularly furanocoumarins — were used across multiple ancient medical traditions for their observable pharmacological effects without knowledge of the specific constituent responsible.

Furanocoumarins have been used by Indian and Egyptian civilizations for more than 3000 years to treat several skin disorders. It was only in the middle of the twentieth century when the photosensitizing and pigment-stimulating agents in these plants were identified. Indians and Egyptians recognized that the ingestion of boiled extract of leaves, seeds, or roots of several plants — such as those of the Apiaceae family native to Egypt and widely distributed in Europe, the Mediterranean, and West Asia — had therapeutic value. These plants were used for the treatment of various dermatological disorders, particularly vitiligo, in the Unani system of medicine. In traditional medicine, fruits of these plants were used as an emmenagogue, as a diuretic, as a blood purifier, and to treat leprosy, urinary, and digestive disorders.

In plants, furanocoumarins play a key role as phytoalexins and they are known for their preeminent involvement in both constitutive and induced plant defense, acting against microorganisms, nematodes, phytophagous insects, herbivores, and plant competitors. It is this intrinsic role in plant defense that drove the co-evolution of high furanocoumarin concentrations in many plants used historically as medicinal herbs.

Essential oils obtained from the peel of the fruits of Citrus bergamia are rich in bergapten and bergamottin, and have been extensively used in external suntan preparations, absorbing light in the near UV region and stimulating the formation of melanin. Bergapten (5-methoxypsoralen), a linear furanocoumarin, was later identified as the key active agent in traditional phototherapy for vitiligo.

The use of furan-containing marine sources such as fish and fish oils has deep roots in coastal traditional diets across Scandinavia, Japan, and the Mediterranean, where high fish consumption was observed to be associated with longevity and cardiovascular health long before the specific contribution of FuFAs was postulated.

4. Key Constituents and Active Compounds

4.1 Furan Fatty Acids (FuFAs)

Furan fatty acids (F-acids) are tri- or tetrasubstituted furan derivatives characterized by either a propyl or pentyl side chain in one of the α-positions; the other is substituted by a carboxyalkyl chain. Fish oil has been found to be rich in monomethyl and dimethyl furan fatty acids, at approximately 1.3 g/100 g lipids. The principal human metabolite of dietary FuFAs is 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF). CMPF is a furan fatty acid metabolite that was first identified in urine and is a protein-bound uremic toxin. CMPF is a strong biomarker of fish and n-3 polyunsaturated fatty acid (PUFA) intake.

4.2 Furanocoumarins

The principal furanocoumarins of pharmacological interest include psoralen, bergapten (5-methoxypsoralen), xanthotoxin (8-methoxypsoralen), isopimpinellin, bergamottin, and 6′,7′-dihydroxybergamottin. Grapefruit juice contains furanocoumarins, specifically bergamottin and 6′,7′-dihydroxybergamottin (DHB), which irreversibly inhibit CYP3A4. Furanocoumarin is a phytochemical, a type of organic compound produced by plants as a defense mechanism against pests and pathogens. Chemically, these compounds are derivatives of coumarin, characterized by a furan ring fused with a coumarin structure. Their primary biological activity stems from their ability to absorb ultraviolet (UV) light, particularly UVA radiation, which can then lead to various photochemical reactions in biological systems.

4.3 Furanones

Furanones are potent superoxide anion scavengers and lipid peroxidation inhibitors. The most studied natural furanone is 2,5-dimethyl-4-hydroxy-3[2H]-furanone (DMHF), identified from pineapple and strawberry.

4.4 Toxic Parent Furan and Methylfurans

The parent furan molecule that arises through food processing is distinct in character from the bioactive furanic derivatives discussed above. Metabolism studies indicate that furan is bioactivated in the liver to a reactive metabolite, cis-2-butene-1,4-dial, by cytochrome P-450 2E1. The binding of this reactive metabolite (BDA) to a range of target molecules leads ultimately to cell and tissue damage, mitochondrial dysfunction, and fibrosis, primarily in the liver. There is clear evidence for the involvement of indirect mechanisms in the carcinogenic mode of action of furan. These include epigenetic changes, oxidative damage to DNA, and regenerative hyperplasia, with all of these effects being accompanied by tissue damage.

5. Mechanisms of Action

5.1 Antioxidant Mechanisms of FuFAs

Furan fatty acids are considered valuable bioactive compounds that can act as antioxidants and radical scavengers, thus protecting sensitive polyunsaturated fatty acids (PUFA) from oxidation. The mechanism behind the radical scavenging is that one lipid radical can react with a furan fatty acid by an addition reaction to the furan ring at position 2 or 5, which leads to opening of the furan ring and formation of a mesomeric radical. The mesomeric radical can then react with a second lipid radical and form a ketal structure, and upon hydrolysis generate dioxoene. In general, the antioxidant function seems to be dictated by the reactivity of the furan fatty acid structure, especially by the extent of methyl substitution.

5.2 Anti-inflammatory Mechanisms

Furan natural derivatives have effective antioxidant activities and exert regulatory effects on various cellular activities by modifying signaling pathways such as MAPK (mitogen-activated protein kinase) and PPAR-γ (peroxisome proliferator-activated receptor gamma). MAPK pathway modulation affects cytokine production and inflammatory gene expression, while PPAR-γ activation is associated with suppression of nuclear factor-κB (NF-κB)-driven pro-inflammatory signaling.

5.3 Antimicrobial Mechanisms

The antimicrobial activity of natural furan compounds is performed through selective inhibition of microbial growth and modification of enzymes. At the cellular level, previous studies have shown that furan derivatives exert their antibacterial effects by disrupting bacterial cell wall synthesis and interfering with nucleic acid function.

5.4 Furanocoumarin Photochemistry

The mechanisms of action of furanocoumarins are complex, but they can generally be divided into two light-dependent and light-independent processes. In their photochemical (light-dependent) mode, linear furanocoumarins intercalate into DNA and, upon absorption of UVA light, form covalent cross-links with pyrimidine bases. The biosynthesis of furanocoumarins can be induced and enhanced by direct exposure to microorganisms, insects, and fungi, as well as by abiotic elicitors, such as UV radiation and physical damage.

5.5 CYP3A4 Inhibition by Furanocoumarins

Furanocoumarins are metabolized by CYP3A4 to reactive intermediates that bond covalently to the active site of the enzyme, causing irreversible inactivation (mechanism-based inhibition). Consequently, CYP3A4 activity in the small intestine is impaired until de novo synthesis returns the enzyme to its previous level. CYP3A4 is the primary enzyme responsible for Phase I metabolism of drugs, foods, and herbs, metabolizing over 30% of all marketed drugs.

6. Scientific Evidence by Area of Use

6.1 Cardiovascular Health

Results from recent studies revealed that several uncommon fatty acids — including furan fatty acids — have favorable effects on cardiometabolic health. FuFAs exhibit potent antioxidant and anti-inflammatory effects, with growing evidence of their role in metabolic health. Recent research suggests that FuFAs may extend benefits beyond omega-3 fatty acids in promoting cardiovascular and metabolic health.

Free furan fatty acid (FuFA) exhibits antioxidant and anti-inflammatory properties, thereby reducing cardiovascular risks in humans. Furanoid fatty acids found in fish and algae function as endogenous antioxidants, protecting cellular membranes from oxidative damage. These specialty fatty acids often occur in low concentrations but exert disproportionate biological effects through highly specific mechanisms.

Furan fatty acids, because of their antioxidant activity, may also play a role in protecting against aspects of cardiovascular disease. Evidence from previous studies implied a favorable effect of furan fatty acids on cardiometabolic health. Clinical trials are required to confirm the direct effect of furan fatty acids on cardiometabolic health by using purified furan fatty acids as treatment. This is an important caveat: the cardiovascular evidence for FuFAs is currently based on observational data and mechanistic studies, not randomized controlled clinical trials.

6.2 Antioxidant Activity

Furan fatty acids are found in plants, algae, and fish, and reported to have some positive health benefits, including anti-oxidant and anti-inflammatory activities, and inhibition of non-enzymatic lipid peroxidation. In laboratory studies of fish oil oxidation, dimethyl furan fatty acids degraded faster than monomethyl ones and also faster than tocopherols upon oxidation. The addition of a monomethyl furan fatty acid (9M5) revealed antioxidant activity: it inhibited the degradation of ω-3 polyunsaturated fatty acids and the formation of primary and secondary lipid oxidation products, and slowed down the degradation of the furan fatty acids and tocopherols. This suggests potential utility of FuFAs as natural antioxidants in lipid-containing food matrices, though human clinical evidence is lacking.

6.3 Metabolic Health and Type 2 Diabetes

The relationship between furan fatty acid metabolites and glucose metabolism is scientifically controversial, with human evidence pointing in opposing directions depending on study context.

Evidence suggesting a protective association: In a prospective cohort study, each standard deviation increase in baseline serum CMPF was associated with an 18% lower risk of type 2 diabetes (relative risk: 0.82, 95% confidence interval [CI]: 0.68, 0.99) but was not associated with chronic kidney disease. In the Guangzhou Nutrition and Health Study, during a median follow-up of 8.8 years, a multivariable-adjusted Poisson regression model was used to investigate the association of baseline serum CMPF with the incidence of type 2 diabetes (1470 participants and 170 incident cases) and chronic kidney disease (1436 participants and 112 incident cases). Mediation analysis suggested that serum CMPF contributed to the inverse association between erythrocyte marine n-3 PUFAs and incident type 2 diabetes, with a proportion mediated of 37% (P-mediation = 0.022).

Evidence suggesting harm: Using metabolomics, researchers showed that CMPF is elevated in the plasma of humans with gestational diabetes mellitus (GDM), as well as impaired glucose-tolerant and type 2 diabetes (T2D) patients. In mice, diabetic levels of plasma CMPF induced glucose intolerance, impaired glucose-stimulated insulin secretion, and decreased glucose utilization. Several recent studies have reported that CMPF plays an important role in diabetes progression by contributing to β-cell failure and decreasing glucose-stimulated insulin secretion. CMPF has also been reported to inhibit mitochondrial respiration, glutathione S-transferase, and drug metabolism in the liver.

Nutritional context: CMPF is a metabolite derived from furan fatty acids, is found in marine animals, and is a possible biomarker of fish intake, which suggests healthier dietary choices. A prospective cohort study including 76 participants showed that fish oil intake increased serum CMPF levels and decreased triglyceride levels in a type 2 diabetes mellitus cohort. Another study of 106 patients showed that 12 weeks of fish consumption increased the CMPF concentration in plasma and did not harm glucose metabolism.

Evidence strength assessment: The evidence on CMPF/furan fatty acids and diabetes is preliminary, observational, and conflicting. The mechanistic data are from rodent and cell models; the epidemiological data are cohort-level associations, not intervention studies. No completed randomized controlled trials of isolated FuFAs on diabetes outcomes are available in the published literature as of 2025.

6.4 Non-Alcoholic Fatty Liver Disease (NAFLD)

In the cross-sectional component of a human study, serum CMPF was found to be associated with lipid profiles in Chinese individuals, suggesting a potentially protective association with non-alcoholic fatty liver disease risk markers. CMPF has also been reported to inhibit mitochondrial respiration, glutathione S-transferase, and drug metabolism in the liver. Interpreting the hepatic effects of CMPF is therefore complex, as both protective and potentially damaging mechanisms have been identified in different models.

6.5 Anti-inflammatory and Antimicrobial Activity

In recent years, many natural furan derivatives have been isolated and their biological effects investigated, with a focus on anti-inflammatory and antimicrobial effects and their effects on the immune system. Furocoumarins from grapefruit were isolated and studied against different bacterial strains; the results indicated that furocoumarins of grapefruit juice were potent inhibitors of both N-acylhomoserine lactone (AI-1) and autoinducer-2 (AI-2) activities, though interference with bacterial growth itself was not observed.

Further studies are needed for isolation and detection of different furan derivatives from natural compounds and investigation of their precise mechanisms for revealing health beneficial effects of these compounds. Evidence strength: Evidence for anti-inflammatory and antimicrobial effects remains largely in vitro or in animal models; no robust human clinical trials specifically testing furan derivatives as anti-inflammatory or antimicrobial agents have been published.

6.6 Anticancer Activity

The general mechanism by which furanocoumarins eliminate cancer cells is based on cell cycle blockage and initiation of programmed death like apoptosis or autophagy. Oxypeucedanin (prangolarin), a furanocoumarin, has shown cytotoxicity activity against HeLa cell line (with an IC50 value of 314 μg/mL), as well as other pharmacological and biological activities including antibacterial, antiarrhythmic, antifungal, channel blocker, antioxidant, allelopathic, and antiestrogenic activity. Much of the current literature pays particular attention to the antitumor activity of atractylone, a furan sesquiterpene, which was found to inhibit the apoptosis of tumor cells and prevent growth, invasion, and migration through different apoptosis pathways and signaling pathways.

Evidence strength: All cancer-related evidence for furan natural derivatives is currently in vitro (cell line) or preclinical (animal). No human clinical trials have evaluated furan derivatives as primary anticancer agents.

6.7 Antidiabetic Activity of Furanocoumarins

The antidiabetic activity of Ducrosia anethifolia Boiss organic extracts, characterized by the presence of eight linear furanocoumarins, has been described. The blood glucose level, redox balance, liver function enzymes, total protein, lipid, and cholesterol levels were significantly normalized by organic extract treatment in male Wister albino rats. The major isolated furanocoumarins acted in vitro in a concentration-dependent manner as inhibitors of carbohydrate metabolizing enzymes (α-amylase, α-glucosidase, and β-galactosidase). Evidence strength: This is preclinical (animal and in vitro) evidence only.

6.8 Ophthalmic Effects of Furanones

The antioxidative activity of one furanone derivative, 4-hydroxy-3(2H)-furanones, was investigated on the onset of cataract in spontaneous cataract rats. This compound, isolated from natural sources such as pineapple and strawberry, inhibited spontaneous cataract formation. Evidence strength: Preclinical only; no human trials are available.

7. Body Systems and Health Areas of Association

The furan ring system is the basic skeleton of numerous compounds possessing cardiovascular activities. These compounds are widely employed as antibacterial, antiviral, anti-inflammatory, anti-fungal, anti-tumor, anti-hyperglycemic, analgesic, and anti-convulsant agents.

• Cardiovascular system: FuFAs as lipid radical scavengers and anti-inflammatory agents; associated with reduced triglycerides in fish-consuming cohorts.
• Metabolic/endocrine system: CMPF's controversial role in pancreatic β-cell function and insulin secretion; association with reduced type 2 diabetes incidence in population cohorts.
• Hepatic system: Association with lipid profile regulation; also a target of furan-induced toxicity via bioactivation by CYP2E1.
• Immune system: MAPK and PPAR-γ pathway modulation affecting cytokine profiles and inflammatory resolution.
• Dermatological system: Furanocoumarins' historically documented photosensitizing effects used therapeutically in vitiligo and psoriasis (PUVA therapy).
• Pharmacokinetic/drug metabolism: Furanocoumarins in grapefruit and other citrus as irreversible inhibitors of intestinal CYP3A4, affecting bioavailability of numerous medications.
• Antimicrobial defense: In vitro evidence for bacteriostatic and bactericidal activity of various furan derivatives.

8. Dosage Forms and Dosages Reported in Studies

Because furans as a class are not commercialized as standardized single-ingredient dietary supplements, dosage data are derived from observational and experimental contexts:

• FuFAs in fish oil: In a controlled oxidation study, the monomethyl furan fatty acid 9-(3-methyl-5-pentylfuran-2-yl) nonanoic acid (9M5) was tested at concentrations of 50–250 µM in an enriched ω-3 fish oil that naturally contained approximately 1.3 g furan fatty acids per 100 g lipids.
• CMPF from fish/fish oil in human studies: A prospective cohort study including 76 participants showed that fish oil intake increased serum CMPF levels, and a study of 106 patients showed that 12 weeks of fish consumption increased the CMPF concentration in plasma and did not harm glucose metabolism. Precise supplementation dosages were not reported in the available summaries.
• Grapefruit furanocoumarin threshold: One whole grapefruit or 200 mL of grapefruit juice is sufficient to cause clinically relevant increased systemic drug concentration and subsequent adverse effects via CYP3A4 inhibition.
• No established supplemental dosages exist for isolated natural furan fatty acids or furanone extracts in human health contexts, as these compounds are not yet available as standardized supplements and no clinical dose-finding trials have been completed.

9. Safety Considerations and Interactions

9.1 IARC Classification of Parent Furan

Furan was evaluated by the International Agency for Research on Cancer (IARC). The IARC concluded that the evidence in humans for the carcinogenicity of furan was inadequate but there was sufficient evidence in experimental animals to classify furan as "possibly carcinogenic to humans" (Group 2B). On the basis of a chronic oral carcinogenicity study in which clear evidence of carcinogenicity was noted in male and female rats and mice, the National Toxicology Program (NTP) classifies furan as "reasonably anticipated to be a human carcinogen."

Based on animal studies, liver damage and liver cancer are the most critical health effects of furan. Furan induces hepatocellular tumors in rats and mice and bile duct tumors in rats with a high incidence. Epidemiological studies are not available. Epidemiological data linking furan with human risk are not available, despite its detection in breast milk and the breath of smokers and non-smokers.

Additional investigations examining how furan causes carcinogenicity in experimental animals have provided evidence that severe liver toxicity typically occurs before there is evidence of carcinogenicity and, at lower doses more relevant to human exposure, furan does not readily cause genetic damage that would increase the risk of tumour formation. While some effects related to liver toxicity in experimental animals have been observed at relatively low doses, current dietary exposure estimations are considerably lower than even those levels.

9.2 EFSA Risk Assessment

The amount of furan ingested via the diet indicates a low health concern for most consumers; for high consumers, exposure is up to three times what would be considered of low concern for public health. The CONTAM Panel noted that the calculated margins of exposure (MOEs) for neoplastic effects of furan are smaller than 10,000, which would indicate a health concern. However, there is uncertainty regarding the carcinogenic mode of action of furan. The Panel considered the resulting MOEs for hepatocellular adenomas and carcinomas as supporting evidence for its conclusion, based on the hepatotoxicity of furan, that the current exposure to furan indicates a health concern.

9.3 Hepatotoxicity Mechanism

Furan's cytotoxicity is linked to its bio-activation via cytochrome P450 enzymes, specifically CYP2E1, leading to the production of cytotoxic metabolites. These metabolites, such as cis-2-buten-1,4-dial, are associated with liver and kidney toxicity. The contributing factors in carcinogenesis are likely to vary according to dose, duration of exposure, and degree of severity of liver cellular damage, inflammation, and compensatory proliferation.

9.4 CMPF as a Uremic Toxin

CMPF is a protein-bound uremic toxin. It has been reported to enhance reactive oxygen species production in human kidney cells and induce renal cellular damage. A major metabolite of furan fatty acids, CMPF, has been reported to be increased in patients who progress from prediabetes to type 2 diabetes, although CMPF is not necessarily associated with impaired glucose metabolism. Other studies report that CMPF levels are lower in subjects with diabetes than control subjects. Plasma CMPF levels increase in subjects who consume fish or fish oil, and in patients with renal failure.

9.5 Furanocoumarin Drug-Herb Interactions (Grapefruit Effect)

Furanocoumarins are the main compounds responsible for the food–drug interactions known as the grapefruit effect, which is caused by the inhibition of CYP3A4-mediated drug metabolism. Because these chemicals are innate to grapefruit, all forms of the fruit (freshly squeezed juice, frozen concentrate, and whole fruit) have the potential to reduce the activity of CYP3A4. Drugs that interact usually share three common features: they are taken orally, normally only a small amount enters systemic blood circulation, and they are metabolized by CYP3A4.

For some drugs such as cyclosporine, simvastatin, and lovastatin, warnings or precautionary statements regarding the potential for a grapefruit juice interaction have been included in product labeling. Cyclosporine and other drugs with a narrow therapeutic index are of particular concern because the extent of an interaction with grapefruit juice is unpredictable. This is due in part to interindividual variation in baseline enteric CYP3A4 content or activity and to variable concentrations of the active inhibitors in the different brands and preparations of grapefruit juice.

Cytochrome isoforms affected by grapefruit components include CYP1A2, CYP2C9, and CYP2D6, but CYP3A4 is the major CYP enzyme in the intestine.

9.6 Phytophotodermatitis

One of the most recognized effects of furanocoumarins is photosensitivity, where the compounds increase the skin's sensitivity to UV light. This can result in a condition known as phytophotodermatitis, characterized by severe sunburn-like reactions, blistering, and hyperpigmentation after skin exposure to furanocoumarins followed by sunlight. For example, handling limes in the sun can cause this reaction.

9.7 Instability and Bioavailability of FuFAs

The availability of chemical standards for free FuFAs is limited. They show poor tolerance toward acidic environments, elevated temperatures, and light exposure. Few accurate and efficient structural elucidation methods have been developed for their non-targeted screening in complex matrices. The challenges of FuFA instability influence their availability and impact on food science.

9.8 Special Populations: Infants

The initial surveys of furan concentrations in heat-treated foods revealed the presence of relatively high furan levels in coffee, sauces, and soups. Importantly, furan is consistently found in commercial ready-to-eat baby foods. The highest exposures to furan were estimated for infants, mainly from ready-to-eat meals. This has been flagged as a specific public health concern by EFSA and other regulatory bodies, as developing infants may be disproportionately vulnerable to hepatotoxic contaminants.

10. Current Research Gaps and Future Directions

A considerable number of furanic compounds demonstrate promising biological activity and could serve as prospective pharmacological substances. The explosive development of furan chemistry in recent decades can change the viewpoint on natural furans. The chemical synthesis of FuFAs is being reviewed, paving the way for future animal and human studies. Clinical trials are required to confirm the direct effect of furan fatty acids on cardiometabolic health by using purified furan fatty acids as treatment.

The principal gaps in the current evidence base are:

• The near-complete absence of randomized controlled human trials using purified furan fatty acids or isolated furanone compounds.
• Unresolved controversy over whether CMPF is protective or harmful to β-cell function and glycemic control.
• Insufficient epidemiological data linking dietary parent furan exposure to human cancer outcomes.
• A need for further studies for isolation and detection of different furan derivatives from natural compounds and investigation of their precise mechanisms for revealing health beneficial effects of these compounds.
• More information is needed about methylated furan compounds to fully understand their potential toxicity.

References

• EFSA — Furan in food: EFSA confirms health concerns (2017)
• Alizadeh M et al. — Recent Updates on Anti-Inflammatory and Antimicrobial Effects of Furan Natural Derivatives. Journal of Inflammation Research, 2020 (PMC7443407)
• Dovepress — Recent Updates on Anti-Inflammatory and Antimicrobial Effects of Furan Natural Derivatives. Journal of Inflammation Research, 2020
• Xu J et al. — Furan fatty acids – Beneficial or harmful to health? Food Chemistry, 2017 (ScienceDirect)
• EFSA CONTAM Panel — Risks for public health related to the presence of furan and methylfurans in food. EFSA Journal, 2017 (PMC7009982)
• Health Canada — Furan: Health Risk Assessment
• ScienceDirect Topics — Furan: An Overview
• Elshoura A et al. — The emerging significance of furan fatty acids in food, nutrition, and potential therapeutic use. PubMed, 2025
• Schröter D et al. — Furan fatty acids in enriched ω-3 fish oil: Oxidation kinetics with and without added monomethyl furan fatty acid as potential natural antioxidant. Food Chemistry, 2020
• Schröter D et al. (PubMed) — Furan fatty acids in enriched ω-3 fish oil. PubMed 2020
• Chen Q et al. — Uncommon Fatty Acids and Cardiometabolic Health. PMC6213525, 2018
• Bruni R et al. — Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest. Molecules, 2019 (PMC6600687)
• Bruni R et al. (MDPI) — Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins. Molecules 2019, 24(11):2163
• PMC9966152 — Bio-Derived Furanic Compounds with Natural Metabolism: New Sustainable Possibilities for Selective Organic Synthesis
• Sadowska-Bartosz I et al. — Furanocoumarins in anticancer therapy – For and against. Fitoterapia, 2020
• Zhang Z et al. — Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study. Journal of Nutrition, 2023
• Zhang Z et al. (PubMed) — Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes. PubMed 2023
• Prentice KJ et al. — The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. PubMed 2014
• Dai W et al. — Serum CMPF is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals. PMC6497611, 2019
• Dai W et al. — Serum CMPF associated with lipid profiles and NAFLD. Journal of Diabetes Investigation, 2019
• Bakhiya N, Appel KE — Toxicity and carcinogenicity of furan in human diet. Archives of Toxicology, 2010
• National Academies Press / NCBI Bookshelf — Furan Acute Exposure Guideline Levels
• NTP 15th Report on Carcinogens — Furan. NCBI Bookshelf
• Bailey DG et al. — Grapefruit–medication interactions: Forbidden fruit or avoidable consequences? CMAJ, 2013 (PMC3589309)
• Bailey DG et al. — Grapefruit–medication interactions. CMAJ, 2013
• New grapefruit cultivars exhibit low cytochrome P4503A4-inhibition activity. Food and Chemical Toxicology, 2020
• BioResources — Antibacterial furan derivatives from the flowers of Chrysanthemum indicum L.
• UC Davis Food Quality — Furan: Chemical Contaminant Overview